Nur77 gene expression levels were involved in different ACTH-secretion autonomy between Cushing’s disease and subclinical Cushing’s disease-Reference-Cited by-同舟云学术

Nur77 gene expression levels were involved in different ACTH-secretion autonomy between Cushing’s disease and subclinical Cushing’s disease

Published:2016 Issue:6 Volume:63 Page:545-554
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Tabuchi Yukiko¹,Kitamura Tetsuhiro¹,Fukuhara Atsunori¹,Mukai Kosuke¹,Onodera Toshiharu¹,Miyata Yugo¹,Hamasaki Toshimitsu²,Oshino Satoru³,Saitoh Youichi⁴,Morii Eiichi⁵,Otsuki Michio¹,Shimomura Iichiro¹

Affiliation:

1. Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan

2. Office of Biostatistics and Data Management, National Cerebral and Cardiovascular Center, Osaka 565-8565, Japan

3. Department of Neurosurgery, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan

4. Department of Neuromodulation and Neurosurgery, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan

5. Department of Pathology, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/63/6/63_EJ15-0695/_pdf

Reference20 articles.

1. 1. De Martin M, Pecori Giraldi F, Cavagnini F (2006) Cushing’s disease. Pituitary 9: 279-287.

2. 2. Sakai K, Horiba N, Sakai Y, Hizuka N, Suda T, et al. (1994) A case of preclinical Cushing’s disease only accompanied by obesity and glucose intolerance. Nihon Naibunpi Gakkai Zasshi 70: 726 (Abstract) (In Japanese).

3. 3. Takao T, Mimoto T, Yamamoto M, Hashimoto K (2001) Preclinical Cushing disease. Arch Intern Med 161: 892-893.

4. 4. Nagai T, Imamura M, Misumi S, Mori M (2002) Subclinical Cushing’s disease accompanied by malignant hypertension and diabetes mellitus. Intern Med 41: 566-570.

5. 5. Minami I, Tateno T, Yoshimoto T, Doi M, Izumiyama H, et al. (2006) Subclinical Cushings disease with amelioration of metabolic comorbidities after removal of pituitary tumor. Intern Med 45: 1231-1235.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pituitary transcription factors in the immunohistochemical and molecular diagnosis of pituitary tumours — a systematic review;Endokrynologia Polska;2021-02-26

2. Genetic basis of Cushing’s disease in children and targeted therapeutic future perspectives;Problems of Endocrinology;2020-12-30

3. Distinct Pattern of Endoplasmic Reticulum Protein Processing and Extracellular Matrix Proteins in Functioning and Silent Corticotroph Pituitary Adenomas;Cancers;2020-10-14

4. Why don’t corticotroph tumors always produce Cushing’s disease?;European Journal of Endocrinology;2019-09

5. Inhibition of Notch signaling attenuates pituitary adenoma growth in Nude mice;Endocrine-Related Cancer;2019-01